Pieris Pharmaceuticals Inc buy BiotechBee
Start price
02.01.23
/
60%
€1.04
Target price
31.12.25
€3.00
Performance (%)
-26.41%
End price
05.05.23
€0.77
Summary
This prediction ended on 05.05.23 with a price of €0.77. The price of Pieris Pharmaceuticals Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.41%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pieris Pharmaceuticals Inc | - | - | - |
iShares Core DAX® | -0.205% | 2.949% | 17.330% |
iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% |
iShares Nikkei 225® | -0.740% | -1.256% | 11.847% |
iShares S&P 500 | 0.267% | 3.240% | 29.308% |
According to BiotechBee what are the pros and cons of Pieris Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Pieris Pharmaceuticals Inc diskutieren
Buy mit Kursziel 3,0
In the thread Trading Pieris Pharmaceuticals Inc
Buy beendet